For the Quarter Ending December 2022
In the fourth quarter of 2022, the Enalapril Maleate API market in North America experienced fluctuations. Prices began to climb in Q4 2022 and continued to do so throughout the second month of the fourth quarter due to high manufacturing costs, numerous logistical issues, and rising inflation. Additionally contributing to the market's stability were rising transportation costs and port congestion at the major ports. Furthermore, the market condition was improved by the slowdown in API output brought on by increased energy prices. Prices begin to decline later in the month of December as a result of weaker inflation and decreased end-user sector demand as the holiday season approaches. In December, the Enalapril maleate API settlement price fell to USD 80425/MT CFR in Los Angeles.
The Asia Pacific Enalapril Maleate API market saw a turbulent fourth quarter in 2022. It was witnessed that the prices would rise till the second month of the quarter due to increased end-user sector demand, several logistical challenges, and rising inflation. The market remained competitive because of rising production costs brought on by rising energy prices and increased domestic output to meet demands from both domestic and foreign markets. The stringent zero covid policies and frequent lockdowns in the Chinese regions have impacted the market. Later in December, as domestic merchants had sufficient stock, Enalapril maleate API prices began to decline. The policies being relaxed and the weak downstream demand influenced the market's ongoing decline. In December, the settlement price for Enalapril maleate API fell to USD 154640/MT FOB Shanghai.
In the fourth quarter of 2022, prices for Enalapril Maleate API fluctuated in the European region. The downstream market for the pharmaceutical sector was seen to have a steady demand for Enalapril maleate API. Price hikes were brought on by ongoing port congestion and supply disruption in the European region in the first two months of Q4 022. Retailers in Europe make the decision to considerably refill their inventory due to the approaching Christmas season and the necessity to prepare for it. However, prices decreased dramatically in December as a result of a fall in inflation, relief from port congestion, and a slight increase in existing inventories among the merchants. The cost of Enalapril Maleate API was USD 173320/MT CFR Hamburg toward the end of Q4 2022.
For the Quarter Ending September 2022
Enalapril maleate prices in the US market had an increasing pricing trend during the third quarter of 2022. As demand for Enalapril Maleate decreased and market supplies were adequate, the drug price started the month negatively. Rising freight costs also impacted enalapril maleate prices in the US. As the third quarter ended, the tight market mood was exacerbated by rising prices, which also moved manufacturing operations. Towards Q3 2022, the prices witnessed record heights due to healthy demand, suspended shipments, and increasing inflation, with values demonstrated at USD 168860 /MT CFR Hamburg with an average quarterly inclination of 1.62%
The Asia Pacific region's market sentiments for Enalapril Maleate API likewise showed an upward trend in the third quarter of 2022. Due to reduced demand and adequate stocks among market players, prices started to decline with the commencement of the third quarter. Strict Zero Covid rules and the enforcement of lockdowns in some of the critical ports of exporting nations stopped trade overall in Q3, which helped the market sentiments for enalapril maleate at the end of Q3. Prices rose due to rising downstream pharmaceutical sector demand in domestic and foreign markets. At the termination of Q3 2022, the value for Enalapril maleate API was demonstrated at USD 155560 /MT FOB Shanghai in China with an average quarterly inclination of 2.47%
Due to increased downstream demand in the market, the European region experienced similar market sentiments in the pricing for enalapril maleate as the APAC region. Due to reduced demand at the beginning of the first half of Q3, prices showed a declining trend, which kept inventories on the upper side. With the start of the second month of Q3, the price experienced a downward trajectory due to increased energy costs brought on by the conflict between Russia and Ukraine. Rerouting activities helped to maintain the market sentiments for Enalapril maleate API at the end of Q3. Additionally, because of Covid restrictions, China's exports were delayed, which reduced the amount of inventory available on the local market and kept prices on the higher side. Towards the termination of Q3, the prices for Enalapril maleate settled at USD 171740 /MT CFR Hamburg with an average quarterly inclination of 0.48%.